The Filter Needles Market was valued at USD 2.03 billion in 2023 and is expected to reach USD 3.68 billion by 2032, growing at a CAGR of 6.85% over the forecast period of 2024-2032.
The report presents key statistical information and emerging trends in the Filter Needles Market, which highlight the increasing clinical requirement for sterile drug preparation and delivery. It highlights the incidence and prevalence of conditions for which injectable therapies are needed, and regional prescribing trends for parenteral drugs. It also includes analysis of filter needle utilization volumes by healthcare facility type and study of the pharmaceutical handling volumes associated with reconstitution. It also proffers a range of perspectives on the healthcare expenditure on drug preparation equipment and the regulatory compliance trends shaping adoption across regions. Key market drivers include growing demand for secure Injection and drug delivery systems in healthcare facilities, fueled by the rising prevalence of chronic diseases and stringent regulations on medication administration.
The U.S. filter needles market has shown a consistent upward trajectory, from USD 0.57 billion in 2023 to USD 1.02 billion by 2032. This reflects a compound annual growth rate (CAGR) of 6.64%, fuelled by the rising demand for aseptic drug preparation in hospitals and clinical settings. The increasing number of chronic diseases and injectable therapies drives the market growth in the region. More than 129 million Americans, or 63% of the adult population, have at least one chronic disease like diabetes or heart disease needing frequent injections, according to the Centers for Disease Control and Prevention (CDC). Furthermore, innovations in medical device technology have improved the safety of filter needles, which now play a crucial role in minimizing contamination risk when preparing drugs.
Drivers:
Growing prevalence of chronic diseases increases medication needs, encouraging wider adoption of filter needles in medical drug preparation.
The increasing number of chronic diseases, including diabetes, cancer, and cardiovascular diseases, is contributing to a significant increase in drug administration by injectable routes. This continuous trend of clinical management suggests the need of the safe and effective drug preparation tools. Filter needles are important devices which help in filtering out particulates, glass shards or rubber particles during vial access. As intravenous and intramuscular drug delivery become more common for chronic disorders, healthcare practitioners are enacting safety measures that require using filter needles whenever drugs are administered. Chronic disease burden due to aging populations worldwide also contributes towards an increase in demand for injectable medications. This guidance is driving the adoption of the use of filter needles in drug administration as standard safety practice in all areas of healthcare environment from hospital to homecare.
Restrain
Limited awareness and inconsistent training in filter needle usage hinder safe and standardized application across healthcare facilities.
Limited awareness among healthcare professionals regarding the importance and correct usage of filter needles continues to affect adoption rates in some regions. In many developing and under-resourced healthcare systems, staff are not consistently trained in the use of filter needles, leading to either improper application or complete avoidance. This results in unsafe drug administration practices and increases the risk of contamination or particulate transfer. Additionally, absence of uniform safety protocols and lack of policy enforcement concerning filtration practices contribute to inconsistent usage. When training programs do exist, they may not prioritize filter needle usage as a critical safety component, thus undermining its significance. This disconnect between product availability and proper clinical application remains a significant hurdle to the widespread adoption and benefits of filter needle technology in healthcare settings.
Opportunities
Expansion of healthcare infrastructure in emerging economies drives potential growth in filter needle adoption across new regions.
The emergence of new hospitals, clinics and diagnostics centers to accommodate the expansion of healthcare systems in emerging economies is facilitating new demand for safe medical equipment like filter needles. In countries in the Asia-Pacific region, Latin America and the Middle East, governments and private players are investing heavily in medical infrastructure, patient safety protocols, and the production of a potential vaccine. With the implementation of international healthcare standards in these regions, the demand for the administration of contamination-free injectable medications has increased. Almost all facilities rely on filter needles because they are vital for the safe preparation of drugs, and there are significant updates for those newly constructed. Furthermore, international NGOs, healthcare aid organizations working in such underserved areas are providing the necessary consumables for safety, as well, such as filter needles. This rapidly evolving medical environment therefore presents a huge opportunity for filter needle manufacturers to gain a deeper global presence.
Challenges
Risk of needle-stick injuries and disposal challenges continue to create safety concerns for healthcare staff and institutions.
Risk of needle-stick injuries during the use or disposal of filter needles remains a significant concern for healthcare workers and institutions. Although safety-engineered devices have come into use, occupational exposure continues due to improper handling, accidental recapping, and unsafe disposal practices. This not only endangers healthcare professionals but also results in additional safety protocol burdens for medical facilities. Furthermore, filter needles, being single-use products, contribute to increasing medical waste, complicating hospital waste management efforts. In regions without appropriate biohazard disposal facilities, used needles present a hazard of environmental and community contamination. These safety and environmental challenges require ongoing training, monitoring, and advancement of safe needle technologies; however, frameworks that address these concerns are not globally adopted and continue to be an ongoing challenge within healthcare ecosystems.
By Raw Material
In 2023, among the product type, the stainless-steel segment accounted for the largest revenue share of 43% in the global filter needles market. Stainless steel's widespread use stems from its durability, corrosion resistance, and biocompatibility qualities essential for medical applications. Stainless steel filter needles have enhanced strength and stability, allowing for more accurate drug delivery processes. As a result, the material is much preferred for use in hospitals and pharmaceutical applications, where the sterilization cycles can be quite intense without damaging the material. Such the segment is also supported by various government initiatives. Government initiatives further bolster this segment's growth. For example, regulatory agencies like the FDA emphasize stringent standards for medical devices to ensure patient safety, indirectly driving demand for high-quality materials like stainless steel. Additionally, technological advancements have led to innovations such as smart filter needles with integrated sensors that enhance safety and reduce errors during drug preparation.
Historically, stainless steel has been preferred due to its cost-effectiveness compared to alternatives like glass. While glass is used in specialized applications requiring chemical inertness or transparency, stainless steel remains dominant because of its versatility across various healthcare settings. For instance, hospitals frequently use stainless steel filter needles in oncology and critical care procedures where contamination risks must be minimized.
By End Use
In 2023, hospitals emerged as the leading end-user segment in the filter needles market, holding a revenue share of 44%. This dominance is due to the high procedural volumes seen by hospitals that require sterile medication administration, as well as strong adherence to strict safety protocols. These filter needles are extensively used across intensive care units and oncology wards to avoid contamination while preparing these drugs. Ministerial statistics underscore the importance of hospitals as big buyers of sophisticated medical devices. For example, CDC data show that U.S. hospitals perform millions of surgical procedures every year, among many other reasons that sterile equipment such as filter needles are required. Some market-leading hospitals have embraced the latest technologies, including smart filter needles with safety technologies.
Hospitals also benefit from favourable reimbursement policies that encourage investment in high-quality medical devices. These policies provide optimal patient outcomes and limit the risk of infections during injectable procedures. Also, hospitals are early adapters of innovations like ergonomic designs and needlestick prevention mechanisms that are embedded in filter needle systems. This need has been exacerbated by the increasing incidence of chronic conditions in hospital environments. Chronic conditions such as diabetes need a high volume of injections which are performed under strict safety protocols that cancer hospitals can deal with only through procurement, thus making them an important stakeholder in this segment of the market, according to data from the Centers for Disease Control. Overall, hospitals' emphasis on patient safety and their capacity to handle large-scale procedures solidify their leading position among end-users.
North America held the largest revenue share 35% of the global filter needle market in 2023. This dominance is due to the region's well-equipped healthcare facilities, extensive adoption of advanced medical devices, and presence of key industry players like Becton Dickinson and Cardinal Health. Injectable drugs and medical devices are subject to stringent safety regulations imposed by the U.S. government, coupled with a rising demand for high-quality filter needles. Healthcare applications have driven implementation of advanced filtration technologies due to strict compliance requirements such as The Food and Drug administration (FDA) sterilization and prevention of contamination standards. Furthermore, the growing clinical burden of chronic diseases in North America (diabetes, cancer, etc.) has resulted in a greater number of injectable therapies being offered, propelling market growth.
On the other side, the Asia-Pacific (APAC) region is estimated to achieve the fastest compound annual growth rate (CAGR) throughout the predicted phase. The likes of China and India are currently experiencing fast economic growth and huge spending on healthcare infrastructure. For example, government projects such as India’s Ayushman Bharat scheme are seeking to make affordable healthcare services more readily available, including by upgrading hospitals, modernizing equipment, and adding a wider range of medical devices such as filter needles. Likewise, China’s National Health Commission has placed greater emphasis on hospital infection control, creating demand for sterile medical equipment. The APAC region’s growth is further fueled by increasing awareness of patient safety and infection prevention protocols. Improving surgical capacity in these nations, combined with the increasing geriatric population requiring regular medical interferences, are driving the demand for filter needles. In 2023, APAC's market share steadily increased as healthcare providers adopted Western-style safety standards and regulations. In 2023, APAC's market share steadily increased as healthcare providers adopted Western-style safety standards and regulations.
Becton, Dickinson and Company (BD) – (BD Blunt Filter Needle, BD Eclipse Filter Needle)
Braun Melsungen AG – (Sterican Filter Needle, B. Braun Medical Filter Needle)
Cardinal Health, Inc. – (Monoject Blunt Fill Needle with Filter, Monoject 5 Micron Filter Needle)
Nipro Corporation – (Nipro Blunt Fill Needle with Filter, Nipro Hypodermic Filter Needle)
Terumo Corporation – (Terumo Blunt Fill Filter Needle, Terumo Hypodermic Filter Needle)
Smiths Medical (ICU Medical) – (Jelco Filter Needle, Blunt Fill Needle with 5 Micron Filter)
Thermo Fisher Scientific Inc. – (Nalgene Syringe Filter Needle, Thermo Scientific Sterile Filter Needle)
Medline Industries, LP – (Medline Blunt Fill Filter Needle, Medline 18G Filter Needle)
Retractable Technologies, Inc. – (VanishPoint Filter Needle, RTI Safety Filter Needle)
Hamilton Company – (Hamilton Microliter Filter Needle, Hamilton Gastight Syringe Needle with Filter)
Kawasumi Laboratories, Inc. – (Kawasumi Filter Needle 18G, KPack II Filter Needle)
EXELINT International Co. – (Exel Filter Needle 18G x 1.5", Exel Blunt Fill Filter Needle)
JCM MED – (JCM Blunt Fill Needle with Filter, JCM Safety Filter Needle)
SolMillennium Medical Group – (SOLCARE Blunt Fill Needle with Filter, SOLM Filter Needle)
HiTech Medical Products – (HiTech Blunt Fill Filter Needle, HiTech Safety Filter Needle)
Vita Needle Company – (Vita Blunt Tip Filter Needle, Vita Industrial Filter Needle)
Thomas Scientific – (Thomas Blunt Filter Needle, Thomas Scientific Filter Needle 18G)
CODAN Medizinische Geräte GmbH & Co KG – (CODAN Filter Needle 18G, CODAN Blunt Fill Filter Needle)
Bastos Viegas S.A. – (BV Filter Needle, BV Blunt Fill Needle with Filter)
Qosina Corp. – (Qosina Filter Needle 5 Micron, Qosina Blunt Fill Filter Needle)
In March 2022, ICU Medical completed the acquisition of Smiths Medical, a move intended to enhance its offerings in infusion therapy and related products, including filter needles. This strategic acquisition is expected to bolster ICU Medical's competitiveness in the market.
in January 15, 2025, Terumo launched its Injection Filter Needle as the first product under its INFINO Development Program. This needle is designed for both hypodermic and intravitreal injections and features an integrated 5-micron polyamide mesh filter to prevent particulate contamination.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 2.03 Billion |
| Market Size by 2032 | USD 3.68 Billion |
| CAGR | CAGR of 6.85% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Raw Material (Stainless Steel, Glass, Others) • By End Use (Hospitals, Ambulatory Surgery Centers, Clinics, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Becton, Dickinson and Company (BD), Braun Melsungen AG, Cardinal Health, Inc., Nipro Corporation, Terumo Corporation, Smiths Medical (ICU Medical), Thermo Fisher Scientific Inc., Medline Industries, LP, Retractable Technologies, Inc., Hamilton Company, Kawasumi Laboratories, Inc., EXELINT International Co., JCM MED, Sol-Millennium Medical Group, Hi-Tech Medical Products, Vita Needle Company, Thomas Scientific, CODAN Medizinische Geräte GmbH & Co KG, Bastos Viegas S.A., Qosina Corp. |
Ans. The projected market size for the Filter Needles Market is USD 3.68 billion by 2032.
Ans: The North American region dominated the Filter Needles Market in 2023.
Ans. The CAGR of the Filter Needles Market is 6.85% during the forecast period of 2024-2032.
Ans: Limited awareness and inconsistent training in filter needle usage hinder safe and standardized application across healthcare facilities.
Ans: The Hospitals segment dominated the Filter Needles Market.
Table of Content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.2 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Drug-Related Therapies (2023)
5.2 Regional Prescription Trends Involving Parenteral Medications (2023)
5.3 Pharmaceutical Drug Handling & Reconstitution Volume, 2023
5.4 Healthcare Spending on Drug Preparation & Administration Equipment (2023)
5.5 Compliance with Sterility Standards and Regulatory Adoption, by Region (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and supply chain strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Filter Needles Market Segmentation, By Raw Material
7.1 Chapter Overview
7.2 Peripheral Catheters
7.2.1 Peripheral Catheters Market Trends Analysis (2020-2032)
7.2.2 Peripheral Catheters Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Central Venous Catheters
7.3.1 Central Venous Catheters Market Trends Analysis (2020-2032)
7.3.2 Central Venous Catheters Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Midline Peripheral Catheters
7.4.1 Midline Peripheral Catheters Market Trends Analysis (2020-2032)
7.4.2 Midline Peripheral Catheters Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Filter Needles Market Segmentation, By End-use
8.1 Chapter Overview
8.2 Hospitals
8.2.1 Hospitals Market Trends Analysis (2020-2032)
8.2.2 Hospitals Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Ambulatory Surgery Centers
8.3.1 Ambulatory Surgery Centers Market Trends Analysis (2020-2032)
8.3.2 Ambulatory Surgery Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Clinics
8.4.1 Clinics Market Trends Analysis (2020-2032)
8.4.2 Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2020-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Regional Analysis
9.1 Chapter Overview
9.2 North America
9.2.1 Trends Analysis
9.2.2 North America Filter Needles Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.2.3 North America Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.2.4 North America Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.2.5 USA
9.2.5.1 USA Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.2.5.2 USA Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.2.6 Canada
9.2.6.1 Canada Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.2.6.2 Canada Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.2.7 Mexico
9.2.7.1 Mexico Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.2.7.2 Mexico Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3 Europe
9.3.1 Eastern Europe
9.3.1.1 Trends Analysis
9.3.1.2 Eastern Europe Filter Needles Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.1.3 Eastern Europe Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.1.4 Eastern Europe Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.5 Poland
9.3.1.5.1 Poland Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.1.5.2 Poland Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.6 Romania
9.3.1.6.1 Romania Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.1.6.2 Romania Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.7 Hungary
9.3.1.7.1 Hungary Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.1.7.2 Hungary Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.8 Turkey
9.3.1.8.1 Turkey Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.1.8.2 Turkey Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.1.9 Rest of Eastern Europe
9.3.1.9.1 Rest of Eastern Europe Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.1.9.2 Rest of Eastern Europe Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2 Western Europe
9.3.2.1 Trends Analysis
9.3.2.2 Western Europe Filter Needles Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.3.2.3 Western Europe Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.4 Western Europe Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.5 Germany
9.3.2.5.1 Germany Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.5.2 Germany Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.6 France
9.3.2.6.1 France Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.6.2 France Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.7 UK
9.3.2.7.1 UK Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.7.2 UK Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.8 Italy
9.3.2.8.1 Italy Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.8.2 Italy Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.9 Spain
9.3.2.9.1 Spain Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.9.2 Spain Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.10 Netherlands
9.3.2.10.1 Netherlands Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.10.2 Netherlands Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.11 Switzerland
9.3.2.11.1 Switzerland Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.11.2 Switzerland Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.12 Austria
9.3.2.12.1 Austria Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.12.2 Austria Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.3.2.13 Rest of Western Europe
9.3.2.13.1 Rest of Western Europe Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.3.2.13.2 Rest of Western Europe Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4 Asia Pacific
9.4.1 Trends Analysis
9.4.2 Asia Pacific Filter Needles Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.4.3 Asia Pacific Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.4.4 Asia Pacific Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.5 China
9.4.5.1 China Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.4.5.2 China Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.6 India
9.4.5.1 India Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.4.5.2 India Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.5 Japan
9.4.5.1 Japan Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.4.5.2 Japan Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.6 South Korea
9.4.6.1 South Korea Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.4.6.2 South Korea Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.7 Vietnam
9.4.7.1 Vietnam Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.2.7.2 Vietnam Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.8 Singapore
9.4.8.1 Singapore Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.4.8.2 Singapore Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.9 Australia
9.4.9.1 Australia Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.4.9.2 Australia Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.4.10 Rest of Asia Pacific
9.4.10.1 Rest of Asia Pacific Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.4.10.2 Rest of Asia Pacific Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5 Middle East and Africa
9.5.1 Middle East
9.5.1.1 Trends Analysis
9.5.1.2 Middle East Filter Needles Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.1.3 Middle East Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.1.4 Middle East Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.5 UAE
9.5.1.5.1 UAE Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.1.5.2 UAE Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.6 Egypt
9.5.1.6.1 Egypt Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.1.6.2 Egypt Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.7 Saudi Arabia
9.5.1.7.1 Saudi Arabia Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.1.7.2 Saudi Arabia Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.8 Qatar
9.5.1.8.1 Qatar Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.1.8.2 Qatar Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.1.9 Rest of Middle East
9.5.1.9.1 Rest of Middle East Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.1.9.2 Rest of Middle East Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2 Africa
9.5.2.1 Trends Analysis
9.5.2.2 Africa Filter Needles Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.5.2.3 Africa Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.2.4 Africa Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2.5 South Africa
9.5.2.5.1 South Africa Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.2.5.2 South Africa Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2.6 Nigeria
9.5.2.6.1 Nigeria Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.2.6.2 Nigeria Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.5.2.7 Rest of Africa
9.5.2.7.1 Rest of Africa Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.5.2.7.2 Rest of Africa Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6 Latin America
9.6.1 Trends Analysis
9.6.2 Latin America Filter Needles Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
9.6.3 Latin America Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.6.4 Latin America Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.5 Brazil
9.6.5.1 Brazil Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.6.5.2 Brazil Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.6 Argentina
9.6.6.1 Argentina Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.6.6.2 Argentina Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.7 Colombia
9.6.7.1 Colombia Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.6.7.2 Colombia Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
9.6.8 Rest of Latin America
9.6.8.1 Rest of Latin America Filter Needles Market Estimates and Forecasts, By Raw Material (2020-2032) (USD Billion)
9.6.8.2 Rest of Latin America Filter Needles Market Estimates and Forecasts, By End-use (2020-2032) (USD Billion)
10. Company Profiles
10.1 Becton, Dickinson and Company (BD)
10.1.1 Company Overview
10.1.2 Financial
10.1.3 Products/ Services Offered
110.1.4 SWOT Analysis
10.2 Braun Melsungen AG
10.2.1 Company Overview
10.2.2 Financial
10.2.3 Products/ Services Offered
10.2.4 SWOT Analysis
10.3 Cardinal Health, Inc.
10.3.1 Company Overview
10.3.2 Financial
10.3.3 Products/ Services Offered
10.3.4 SWOT Analysis
10.4 Nipro Corporation
10.4.1 Company Overview
10.4.2 Financial
10.4.3 Products/ Services Offered
10.4.4 SWOT Analysis
10.5 Terumo Corporation
10.5.1 Company Overview
10.5.2 Financial
10.5.3 Products/ Services Offered
10.5.4 SWOT Analysis
10.6 Smiths Medical (ICU Medical)
10.6.1 Company Overview
10.6.2 Financial
10.6.3 Products/ Services Offered
10.6.4 SWOT Analysis
10.7 Thermo Fisher Scientific Inc.
10.7.1 Company Overview
10.7.2 Financial
10.7.3 Products/ Services Offered
10.7.4 SWOT Analysis
10.8 Medline Industries, LP
10.8.1 Company Overview
10.8.2 Financial
10.8.3 Products/ Services Offered
10.8.4 SWOT Analysis
10.9 Retractable Technologies, Inc.
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
10.10 Hamilton Company
10.9.1 Company Overview
10.9.2 Financial
10.9.3 Products/ Services Offered
10.9.4 SWOT Analysis
11. Use Cases and Best Practices
12. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments:
By Raw Material
Stainless Steel
Glass
Others
By End Use
Hospitals
Ambulatory Surgery Centers
Clinics
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Gene Synthesis Market size was valued at USD 2.28 billion in 2023 and is expected to grow to USD 9.64 billion by 2032 and grow at a CAGR of 17.41% over the forecast period of 2024-2032.
The Proteomics Market Size was valued at USD 30.61 billion in 2023 and is expected to reach USD 96.35 Billion by 2032, growing at a CAGR of 13.61% from 2024-2032.
The Respiratory Syncytial Virus Therapeutics (RSV) Market size was USD 1.37 Bn in 2023 & will reach USD 4.64 Bn by 2032 & grow at a CAGR of 14.5%.
The Computerized Physician Order Entry Market size was valued at USD 1.84 billion in 2023 and is expected to grow to USD 3.27 billion by 2032 and grow at a CAGR of 6.63% over the forecast period of 2024-2032.
The MRNA Therapeutics Contract Development & Manufacturing Market Size was valued at USD 3.12 billion in 2023, expected to reach USD 8.09 billion by 2032, growing at an 11.18% CAGR.
The Immunology Market Size was valued at USD 97.58 Billion in 2023, and is expected to reach USD 254.23 Billion by 2032, and grow at a CAGR of 11.8%.
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
